JPH01148812A - Production of inorganic fiber - Google Patents
Production of inorganic fiberInfo
- Publication number
- JPH01148812A JPH01148812A JP63243933A JP24393388A JPH01148812A JP H01148812 A JPH01148812 A JP H01148812A JP 63243933 A JP63243933 A JP 63243933A JP 24393388 A JP24393388 A JP 24393388A JP H01148812 A JPH01148812 A JP H01148812A
- Authority
- JP
- Japan
- Prior art keywords
- fiber
- fibers
- bone
- melting
- inorganic fiber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012784 inorganic fiber Substances 0.000 title claims abstract description 26
- 238000004519 manufacturing process Methods 0.000 title claims description 16
- 239000000835 fiber Substances 0.000 claims abstract description 54
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 238000002844 melting Methods 0.000 claims abstract description 9
- 230000008018 melting Effects 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims description 13
- 230000008569 process Effects 0.000 claims description 4
- 238000005352 clarification Methods 0.000 claims 1
- 238000010309 melting process Methods 0.000 claims 1
- 239000001506 calcium phosphate Substances 0.000 abstract description 14
- 239000011575 calcium Substances 0.000 abstract description 12
- 229910000389 calcium phosphate Inorganic materials 0.000 abstract description 11
- 235000011010 calcium phosphates Nutrition 0.000 abstract description 11
- 239000000155 melt Substances 0.000 abstract description 9
- 239000000203 mixture Substances 0.000 abstract description 8
- 239000000292 calcium oxide Substances 0.000 abstract description 7
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 abstract description 6
- 229910052588 hydroxylapatite Inorganic materials 0.000 abstract description 4
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 abstract description 4
- 238000007664 blowing Methods 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 3
- 238000007670 refining Methods 0.000 abstract description 2
- GBNXLQPMFAUCOI-UHFFFAOYSA-H tetracalcium;oxygen(2-);diphosphate Chemical compound [O-2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GBNXLQPMFAUCOI-UHFFFAOYSA-H 0.000 abstract description 2
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 abstract 6
- 235000012255 calcium oxide Nutrition 0.000 abstract 3
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 abstract 1
- 239000000920 calcium hydroxide Substances 0.000 abstract 1
- 235000011116 calcium hydroxide Nutrition 0.000 abstract 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 description 44
- 230000007547 defect Effects 0.000 description 27
- -1 calcium carbonate Chemical compound 0.000 description 14
- 239000000463 material Substances 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 7
- 239000000243 solution Substances 0.000 description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 230000011164 ossification Effects 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 3
- 235000019731 tricalcium phosphate Nutrition 0.000 description 3
- 229940078499 tricalcium phosphate Drugs 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 208000005422 Foreign-Body reaction Diseases 0.000 description 2
- 235000002918 Fraxinus excelsior Nutrition 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000002956 ash Substances 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 229910010293 ceramic material Inorganic materials 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000000399 orthopedic effect Effects 0.000 description 2
- 230000002188 osteogenic effect Effects 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000002759 woven fabric Substances 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 208000006386 Bone Resorption Diseases 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000008312 Tooth Loss Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical compound [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 description 1
- 229910000387 ammonium dihydrogen phosphate Inorganic materials 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- ZRIUUUJAJJNDSS-UHFFFAOYSA-N ammonium phosphates Chemical compound [NH4+].[NH4+].[NH4+].[O-]P([O-])([O-])=O ZRIUUUJAJJNDSS-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 229910052593 corundum Inorganic materials 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 210000001621 ilium bone Anatomy 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 235000019837 monoammonium phosphate Nutrition 0.000 description 1
- 208000008798 osteoma Diseases 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical group [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 229910001845 yogo sapphire Inorganic materials 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Glass Compositions (AREA)
- Inorganic Fibers (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は生体との現和性が良好でかつ新生骨形成能を有
し、かつ複雑な形状をした骨欠損部位にもきわめて容易
に適合させうる骨欠損部及び空隙部充填剤としての無機
ファイバーの製造方法に関する。[Detailed Description of the Invention] [Field of Industrial Application] The present invention has good compatibility with living organisms, has the ability to form new bone, and is extremely easily adapted to bone defect sites with complex shapes. The present invention relates to a method for producing inorganic fibers as fillers for bone defects and voids.
[従来の技術J
外科あるいは整形外科の分野においては、骨折や骨腫
の切除などにより骨に欠損部あるいは空隙部を生じ、ま
た歯科の分野においても歯WJ験漏による顎骨の消耗欠
損等が起こり、当該個所の補綴を必要とする場合にしば
しば遭遇する。 従来かかる場合には患者本人の腸骨等
を切除し、骨欠損個所に充填し、骨組織の欠損あるいは
空隙をうめるとともに当該組織の回復治癒を早めるとい
う方法が多くの場合用いられている。しかし、この方法
を用いるには損傷個所以外の正常な骨組織を切除する必
要があることから、HA者の苦痛は大きく、しかも手術
に当り、多大の労力を要する。[Conventional technology J] In the field of surgery or orthopedics, fractures and osteomas
Defects or voids are created in the bone due to removal of teeth, and in the field of dentistry, wear-and-tear defects of the jawbone due to tooth loss occur, which often requires prosthesis. Conventionally, in many cases, a method has been used in which the patient's own iliac bone or the like is removed and filled into the bone defect site to fill the bone tissue defect or gap and to hasten the recovery and healing of the tissue. However, using this method requires removal of normal bone tissue other than the damaged area, which causes great pain to people with HA and requires a great deal of labor during the surgery.
さらに、骨欠損部等が大きな場合には、それに埋込むだ
けの充分な量の自家骨を採取できるとは限らず、不足分
については何らかの代用物を用いることを余儀なくされ
る。この代用物としては、たとえば同種骨、異種骨があ
るが埋込んだ生体組織と拒絶反応を伴なうことなどの点
に問題が残されており、手術後の経過は必ずしも良好と
はいえず、未だ実用段階には至っていない。Furthermore, if the bone defect is large, it is not always possible to harvest a sufficient amount of autologous bone to fill it, and some kind of substitute must be used to make up for the shortage. As a substitute, for example, allogeneic bone and xenogeneic bone are available, but there are still problems such as rejection reactions with the implanted living tissue, and the postoperative course is not necessarily good. , has not yet reached the practical stage.
このようなことから、骨欠損部及び空隙部に充填した場
合生体親和性に優れ、当該欠損個所並びにその周辺部に
おける遺骨作用を促進し、骨ml&欠損個所の構造機能
を修復及び回復せしめる人■材料の開発が望まれている
。For this reason, when filling bone defects and voids, it has excellent biocompatibility, promotes the function of ashes in the defect and its surrounding area, and restores and restores the structural function of the bone ml and defect. Development of materials is desired.
生体の硬組織代任物質としては、各種金属合金及び有機
物等が用いられてきたが、生体内における環境下での溶
解劣化若しくは生体に対し凝性を有し、異物反応を伴う
といわれており、現在では生体との親和性に優れ、かつ
上記の欠点のないセラミックス系材料が用いられつつあ
る。 このセラミックス系材料の中でも生体親和性に優
れたアルミナ、カーボン、りん酸三カルシウムあるいは
ヒドロキシアパタイトの焼結体若しくは単結晶からなる
人工骨9人工歯根などが開発されつつあり注「−1を築
めている。Various metal alloys and organic substances have been used as hard tissue substitutes for living organisms, but they are said to deteriorate due to dissolution in the environment of living organisms, have coagulability with living organisms, and are accompanied by foreign body reactions. Currently, ceramic materials are being used that have excellent compatibility with living organisms and do not have the above-mentioned drawbacks. Among these ceramic materials, artificial bones 9 and artificial tooth roots made of sintered bodies or single crystals of alumina, carbon, tricalcium phosphate, or hydroxyapatite, which have excellent biocompatibility, are being developed. ing.
[末完(!■の[1的:解決すべき問題点]しかしなが
ら、これらセラミックス系インブラント材はいずれもセ
ラミックス材料共通の硬くてもろいという欠点を有し、
現在のところこれらの材料として充分実用に供し得る状
懲には至っていない6 さらにこれら焼結体若しくは単
結病体からなるセラミックスのブロックを骨欠損部に充
填する試みもなされてはいるが、複誰な形状の骨欠損部
に充填するにあたり該ブロックと骨組織との間に不均一
な間隙が残存することなどから、充填の目的を達成する
ことはできず、−・万たとえばアルミナの場合には、骨
組織より著しイ硬いため充填材周辺でその刺激による骨
吸収が起こるなどの問題点があり、いまだ実用の域には
達していない。[Part 1: Problem to be solved] However, all of these ceramic implant materials have the common drawback of being hard and brittle.
At present, these materials have not yet reached a state where they can be put to practical use.6 Furthermore, attempts have been made to fill bone defects with ceramic blocks made of these sintered bodies or single diseased bodies; When filling a bone defect with a different shape, the purpose of filling cannot be achieved because uneven gaps remain between the block and the bone tissue.For example, in the case of alumina, Since it is significantly harder than bone tissue, there are problems such as bone resorption due to stimulation around the filling material, and it has not yet reached the level of practical use.
従って、本発明の一目的は生体親和性に優れ、しかも異
物反応を伴わず短期間に生体硬M1mと一体化する骨欠
損部及び空隙部充填材である無機ファイバーの製造方法
を先ず提供することにある。Therefore, one object of the present invention is to first provide a method for manufacturing an inorganic fiber that is a material for filling bone defects and voids, which has excellent biocompatibility and integrates with the biological hardness M1m in a short period of time without any foreign body reaction. It is in.
本9.明の他の目的は充填部における遺骨作用を促進し
、骨組織欠損個所の構造及び機老を特に速やかに修復及
び回復せしめる骨欠損部及び空隙部充填材である無機フ
ァイバーの製造方法を提供することにある。Book 9. Another object of the present invention is to provide a method for producing an inorganic fiber as a filling material for bone defects and voids, which promotes the ashes action in the filling area and particularly quickly repairs and restores the structure and aging of bone tissue defects. There is a particular thing.
[本発明の構成:問題を解決するための手段]本発明に
よれば、熔融後Ca / Pモル比が0.3以上4.0
以下となり、かつCao+P2O5が80重量[96j
未満15!#、贋c%]以上となる原料を、熔融−[程
とファイバー化工程とによりファイバーとする無機フィ
バ−の製造方法が提供される。また、前記構成の製造方
法によりファイバー化されたファイバーをりん酸基を含
みかつ[pH1が2ないし7である溶液に浸漬すること
により、特に骨生成能を増大させた無機ファイバーの製
造方法が提供される。[Structure of the present invention: Means for solving the problem] According to the present invention, the Ca/P molar ratio after melting is 0.3 or more and 4.0.
and Cao+P2O5 is 80 weight [96j
Less than 15! A method for producing an inorganic fiber is provided, in which a raw material having an amount of at least 10% is made into fibers by melting and fiberizing steps. Further, there is provided a method for producing inorganic fibers having particularly increased osteogenic ability by immersing fibers made into fibers by the production method having the above-mentioned structure into a solution containing phosphate groups and having a pH of 2 to 7. be done.
本発明のJSSラフアイバーりんおよびカルシウムの原
料としてはりん酸四カルシウム、ヒドロキシアパタイト
、りん酸三カル・ンウム、プルッシャイ;・、モネタイ
)7りんおよびカルシウムを含む化合物を単独で、若し
くはこれらと生石灰、消石灰、炭酸カルシウム等カルシ
ウムを含む化合物又はりん酸三アンモニウム、りん酸−
水素アンモニウム、りん酸ナトリウム、りん酸カリウム
、りんlv′vりんを含む化合物のうちから選ばれた1
種若しくは2種以上の混合物を、更に、前記カルシウム
を含む化合物とりんを含む化合物のそれぞれから選ばれ
た1種若しくは2種以上の混合物を適宜使用することが
でJる。 また、CaO及びP2O5以外の成分の合計
を20[%]以1185[%]未満とする原料としては
、アルミニウム。As raw materials for the JSS rough eye bar phosphorus and calcium of the present invention, compounds containing tetracalcium phosphate, hydroxyapatite, tricalcium phosphate, prussia; , compounds containing calcium such as calcium carbonate, or triammonium phosphate, phosphoric acid
1 selected from compounds containing ammonium hydrogen, sodium phosphate, potassium phosphate, and phosphorus lv'v phosphorus
It is possible to appropriately use a species or a mixture of two or more thereof, and one or a mixture of two or more selected from each of the calcium-containing compound and phosphorous-containing compound. Further, the raw material for making the total content of components other than CaO and P2O5 20 [%] or more and less than 1185 [%] is aluminum.
珪素、ナトリウム等を含む化合物から選ばれた1種また
は2a以上の混合物を適宜使用することができる。 な
おこれらに代え、天然に存する物質例えば動物の骨やカ
オリン等も、生体にとって有害となる成分たとえばひ素
、カドミウム等を含んでいないか又はその含有量が少量
であれば使用できる。One kind or a mixture of two or more compounds selected from compounds containing silicon, sodium, etc. can be used as appropriate. In place of these, naturally occurring substances such as animal bones and kaolin can also be used as long as they do not contain components harmful to living organisms such as arsenic, cadmium, etc., or the content thereof is small.
本発明の無機ファイバーはたとえば前述した原料を適宜
混合し、該混合物を底部にノズルを有するつぼに入れ熔
融し、清澄化させ、底部のノズルより熔融物を流出させ
、これに高圧気体をふきつけることにより綿状ファイバ
ーとすることができ、−実流出物をドラムにまきとらせ
ることにより長ファイバーとすることができる。The inorganic fiber of the present invention can be produced by, for example, appropriately mixing the above-mentioned raw materials, melting the mixture in a crucible with a nozzle at the bottom, clarifying it, letting the melt flow out from the nozzle at the bottom, and blowing high-pressure gas onto it. Cotton-like fibers can be obtained by this process, and long fibers can be obtained by winding the actual effluent on a drum.
該無機ファイバーはCa / Pモル比が0.3以上4
.0以下であり、かつCaO+P20s含有量が80[
%]未満15[%]以との範囲にあることが必要である
。Ca/Pが0.3未満の場合には熔融物の粘度が小さ
くなりすぎるため、ファイバーとなすことが困難なため
であり、Ca / Pが4.oを越える場合、及びCa
O+P205含有量が80[%]以上の場合には、とも
に原料の融点が著しく高くなり、熔融できなくなるか又
は熔融できたとしても熔融物の粘度がファイノく−とす
るためには大きすぎるため、ファイバーを作りえないた
めである。一方CaO+PzO5含有量が15「%」未
満の場合には生体親和性が悪くなり、かつ新生骨生成能
も低くなり、骨組織の修復及び回復が遅くなるため好ま
しくない。The inorganic fiber has a Ca/P molar ratio of 0.3 or more4
.. 0 or less, and the CaO+P20s content is 80 [
%] and 15[%] or more. This is because when Ca/P is less than 0.3, the viscosity of the melt becomes too small, making it difficult to form fibers. o, and Ca
When the O+P205 content is 80 [%] or more, the melting point of both raw materials becomes extremely high, and it becomes impossible to melt, or even if it can be melted, the viscosity of the melt is too high to make it fine. This is because fibers cannot be created. On the other hand, if the CaO+PzO5 content is less than 15%, it is not preferable because the biocompatibility is poor and the ability to generate new bone is also low, which slows down the repair and recovery of bone tissue.
本発明の無機ファイバーの製造方法はその表面にりん酸
カルジム化合物を有せしめる方法が好ましく、りん酸カ
ルシウム化合物を無機ファイバー表面に有せしめる効果
はS*ファイバーの生体宸相性を更に改良し、新生骨生
成能をより大きくすることにより生体骨組織の修復及び
回復ならびに骨組織と充填材の一体化をより早くするこ
とにある。The method for producing the inorganic fiber of the present invention is preferably a method in which a calcium phosphate compound is provided on the surface of the inorganic fiber.The effect of providing a calcium phosphate compound on the surface of the inorganic fiber is to further improve the biocompatibility of the S* fiber and to promote new bone formation. The aim is to repair and recover living bone tissue and to integrate bone tissue and filling material more quickly by increasing the production capacity.
無機ファイバーの表面にりん酸カルシウム化合物を有せ
しめる方法としては、無機ファイバーをりん酸水溶液と
アンモニア水の混合により、又はりん酸−水素アンモニ
ウム、りん酸二水素アンモニウム又はりん酸三アン舌ニ
ウムの水溶液又はこれらの混合溶液、又はこれらとりん
酸水溶液若しくはアンモニア水とを混合し所望の[pH
1となし、これに浸漬させることにより該溶液中に存在
するりん酸基と無機ファイバーから溶出するカルシウム
イオンとを反応せしめ、りん酸カルシウム化合物をファ
イバーの表面に析出させる方法を用いることができる。Methods for providing a calcium phosphate compound on the surface of inorganic fibers include mixing the inorganic fiber with an aqueous solution of phosphoric acid and aqueous ammonia, or using an aqueous solution of ammonium hydrogen phosphate, ammonium dihydrogen phosphate, or trianthonium phosphate. Or a mixed solution of these, or a mixture of these and an aqueous solution of phosphoric acid or aqueous ammonia to achieve the desired pH.
A method can be used in which a calcium phosphate compound is precipitated on the surface of the fiber by immersing it in the solution to cause the phosphoric acid groups present in the solution to react with the calcium ions eluted from the inorganic fiber.
上記無機ファイバー表面にりん酸カルシウム化合物を析
出させるりん酸基を含む溶液の[pH]は2〜7にある
ことが必要である。溶液の[pH]が2未満の場合には
無機ファイバーが劣化し、ファイバーの強度が著しく低
下するためこれを充填材として使用するのに1分な強度
のものが得られないためである。一方[pH1が7を超
える場合には無機ファイバー表面に析出するりん酸カル
シウム化合物がきわめてわずかとなるため、表面改質の
効果が殆ど期待でSないためである。゛
なお、篤機ファイバーの表面にりん酸カルシウム化合物
を右せしめる方法としては、ブルツシャイト、りん酸三
カルシウム、ヒドロキシアパタイト等のりん酸カルシウ
ム化合物のスラリーを無機ファイバーの表面に付着せし
め、これを乾燥してりん酸カルシウム化合物を該ファイ
バーの表面に固定する方法等も使用し得る。It is necessary that the pH of the solution containing a phosphoric acid group to precipitate a calcium phosphate compound on the surface of the inorganic fiber is between 2 and 7. This is because if the [pH] of the solution is less than 2, the inorganic fibers will deteriorate and the strength of the fibers will drop significantly, making it impossible to obtain a fiber with sufficient strength to be used as a filler. On the other hand, when pH 1 exceeds 7, very little calcium phosphate compound precipitates on the surface of the inorganic fibers, so the effect of surface modification is hardly expected.゛The method of applying a calcium phosphate compound to the surface of the Atsuki fiber is to apply a slurry of calcium phosphate compounds such as wurtzcheid, tricalcium phosphate, hydroxyapatite, etc. to the surface of the inorganic fiber, and then dry it. A method of fixing a calcium phosphate compound to the surface of the fiber can also be used.
表面改質は単にファイバーのみでなく前述した長ファイ
バーを織物状となしたものについても同様に行うことが
でき、この織物状の表面改質したものを骨欠損部周囲に
巻きつける方法等に使用することも当然可能である。Surface modification can be performed not only on fibers but also on the aforementioned long fibers in the form of a woven fabric, and this surface-modified woven fabric can be used in methods such as wrapping around bone defects. Of course, it is also possible to do so.
[作用]
本発明の製造方法では原料を混合し、底部にノズルを有
する、るつぼで熔融し、気泡等を飛散させ清澄化させた
後ノズルより流出させるが、Al2O3とSiO2など
の成分が相当に含有されているので、非常に紡糸しやす
いから、殆ど断糸することなくフィアバー化することが
できる。[Function] In the production method of the present invention, raw materials are mixed, melted in a crucible with a nozzle at the bottom, air bubbles etc. are scattered and clarified, and then flowed out from the nozzle, but components such as Al2O3 and SiO2 are considerably contained. Since it is very easy to spin, it can be made into fibers with almost no breakage.
このような形状とすることにより骨欠損部及び空隙iの
充填材としての使用に際し、その形状をきわめて容易に
かつ自由に変えうることとなり。By having such a shape, the shape can be changed very easily and freely when used as a filling material for bone defects and voids i.
また塊状物に比して表面積を大とすることができること
から、新生骨の生成量も多くしうる。更に該形状とする
ことにより該ファイバーを充填材として使用した場合、
連続した空孔を付与することができ、したがって骨形成
成分が充填材内部にまで進入することになる結果、骨組
織欠損個所の修復及び回復、更には生体硬組織と充填材
の一体化を著しく早めることができる。Furthermore, since the surface area can be made larger than that of a lump, the amount of new bone produced can also be increased. Furthermore, when the fiber is used as a filler by forming it into the shape,
Continuous pores can be created, allowing the osteogenic components to penetrate into the filling material, which significantly improves the repair and recovery of bone tissue defects and the integration of the living hard tissue and the filling material. You can hasten it.
無機ファイバーの表面に析出させたりん酸カルシウム化
合物の種類は詳細には確定し得ないが、x!l解析の結
果より、りん酸基を含む前記溶液の[pH]が低い場合
はブルツシャイトが、[pH1が高い場合はアパタイト
が主体となっているものと思われる。Although the type of calcium phosphate compound deposited on the surface of the inorganic fiber cannot be determined in detail, x! From the results of the l analysis, it seems that when the pH of the solution containing phosphate groups is low, wurtzcheid is the main component, and when the pH is high, the main component is apatite.
以下本発明を実施例により更に具体的に説明する。The present invention will be explained in more detail below with reference to Examples.
「実施例1」
第1表に示す原料を混合し底部にノズルを有する、るつ
ぼにて熔融し、該熔融物を十分清澄化後るつぼのノズル
より熔融物を流出させ該流出物をドラムに巻きとること
により長ファイバーの作製を試みた。 結果を第1表に
示す。"Example 1" The raw materials shown in Table 1 were mixed and melted in a crucible having a nozzle at the bottom, and after the melt was sufficiently clarified, the melt was flowed out from the nozzle of the crucible and the flow was wound in a drum. We attempted to create long fibers by taking the following steps. The results are shown in Table 1.
この結果、Ca / Pが0.2の場合はいずれもファ
イバー化できなかったが、これはこれらを熔融した場合
の熔融物の粘度が低すぎるためであった。一方、Ca/
Pが0.3又はl−7の場合でCaO+P2O5が90
[%]の場合には一応熔融物となるが、これらについて
はファイバーを作製するに当り、しばしば断糸し連続し
てファイバー化することは困難であった。Ca/Pが4
.0で、かツCa O+ P205が90[%]の場合
及びCa / Pが5.0の場合には1700[’C]
にても混合した原料が熔融せず、ファイバーを得ること
はできなかった。As a result, it was not possible to form fibers in any case where Ca/P was 0.2, but this was because the viscosity of the melt when these were melted was too low. On the other hand, Ca/
When P is 0.3 or l-7, CaO + P2O5 is 90
In the case of [%], it becomes a molten product, but when producing fibers, it was often difficult to break the fibers and continuously form them into fibers. Ca/P is 4
.. 0, and when Ca O + P205 is 90 [%] and Ca / P is 5.0, it is 1700 ['C]
However, the mixed raw materials did not melt and no fiber could be obtained.
以上あげた以外の場合については、いずれの場合にも、
はぼ断糸することなく長ファイバーを作製しえた。In any case other than those listed above,
Long fibers could be produced without cutting.
第1表
[実施例2]
実施例における試験No、7.9,11,13.17.
19で作製したファイバーを犬の大腿骨に人工的に作製
した骨欠損部(3m mφ7×4mmL)に充填し、1
2iJ間経過後の骨欠損部の様子を観察した。その結果
、試験No、7.9゜13.17.19のファ・fバー
を使用した場合には、いずれの場合も、周囲の骨組織と
殆ど一体化しており、充填材と周囲の骨組織との境界は
明確でなかった。しかしながら試験No、llのファイ
バーを使用した場合には充填したファイバー表面にわず
かに新生骨の生成がみとめられるのみで周囲の骨組織と
充填材とは明確に区別することができた。Table 1 [Example 2] Test No. in Example, 7.9, 11, 13.17.
The fiber prepared in step 19 was filled into a bone defect (3 mm mφ7 x 4 mm L) artificially created in the femur of a dog.
The condition of the bone defect area was observed after 2 iJ had passed. As a result, when F-bar of test No. 7.9°13.17.19 was used, in all cases, it was almost integrated with the surrounding bone tissue, and the filling material and surrounding bone tissue The boundaries were not clear. However, when test No. 1 fibers were used, only slight new bone formation was observed on the filled fiber surface, and the surrounding bone tissue and the filling material could be clearly distinguished.
[実施例3]
実施例1における試験No、7.13.19と同一組成
の原料を用い実施例1と同様に底部にノズルを有するる
つぼ中に熔融物を作製し、該熔融物を底部のノズルより
流出させ、これに高圧空気をふきつけることにより綿状
のファイバーの作製を試みた。[Example 3] Using raw materials having the same composition as Test No. 7.13.19 in Example 1, a melt was prepared in a crucible having a nozzle at the bottom in the same manner as in Example 1, and the melt was poured into a crucible at the bottom. An attempt was made to produce cotton-like fibers by blowing high-pressure air onto the flow from a nozzle.
この結果いずれの場合においても綿状のファイバーを得
ることができた。As a result, flocculent fibers could be obtained in all cases.
これらを犬の大腿骨に人工的に作製した骨欠損部(3m
mφX4mmL)に充填し、以後の経過を観察した。These were artificially created bone defects (3 m
mφ x 4 mmL), and the subsequent progress was observed.
その結果いずれの場合においても充填後4週間ですで
に充填したファイバー表面に新生骨が多量に生成してい
ることが認められた。As a result, in all cases, it was found that a large amount of new bone had already been generated on the surface of the filled fibers 4 weeks after filling.
[実施例41
実施例1における試験No、7.13.19で作製した
ファイバーを用い、該ファイバーをそれぞれ、りん酸−
水素アンモニウムを10E%]含みりん酸又はアンモニ
ヤ水にて[pH]1.0゜2.0,4.0.6−0.7
.0,8.0にした水溶液中にそれぞれ30分間ずつ浸
漬し、ファイバーの表面処理を行った。 このようにし
て得たファイバー表面を走査型電子顕微鏡にてm察した
ところ、いずれの場合も[pH11,0で処理したファ
イバーについては、ファイバー表面が侵され大きな凸凹
が見られた。 [pH]a、oで処理したファイバ
ーはファイバー表面に殆ど析出物状のものは見られなか
った。[pH]2.0゜4.0,6.0,7.0で処理
を行った場合のファイバー表面は析出物にておおわれて
いたが、中でも、[pH] 4.0,6.0で処理した
ものにおいては1表面がより均一に析出物でおおわれて
いた。[Example 41 Using the fibers prepared in Test No. 7.13.19 in Example 1, the fibers were treated with phosphoric acid.
In phosphoric acid or ammonia water containing 10E% ammonium hydrogen [pH] 1.0°2.0, 4.0.6-0.7
.. The fibers were surface-treated by immersing them in aqueous solutions adjusted to 0 and 8.0 for 30 minutes, respectively. When the surface of the fiber thus obtained was observed using a scanning electron microscope, in all cases, the fiber surface was attacked and large irregularities were observed for the fibers treated at pH 11.0. Almost no precipitates were observed on the fiber surface of the fibers treated at [pH] a and o. The fiber surface was covered with precipitates when treated at [pH] 2.0°, 4.0, 6.0, and 7.0; In the treated sample, one surface was more uniformly covered with precipitates.
試験No、13で作製したファイバーを上記各[pH1
で処理した場合の引張強さを第2表に示す。The fibers prepared in Test No. 13 were subjected to each of the above [pH 1
Table 2 shows the tensile strength when treated with .
第2表
第2表(続き)
この結果によれば、[pH1が1.0の場合には引張強
さが著しく低下していた。Table 2 Table 2 (Continued) According to the results, the tensile strength was significantly reduced when pH 1 was 1.0.
[実施例%]
実施例1における試験No、7.19で作製したファイ
バー及び、該ファイバーを実施例4と同様の方法にて、
[pH12,0,4,0,6,0,7,0,8,0にて
表面処理を行ったファイバーを用い、犬の大圏骨に人工
的に作製した骨欠損部(3mmφX4mmL)に充填し
、3週間経過後の新生骨の生成の様子を観察した。[Example %] The fiber produced in Test No. 7.19 in Example 1 and the fiber in the same manner as in Example 4,
[Using fibers surface-treated at pH 12, 0, 4, 0, 6, 0, 7, 0, 8, 0, it was filled into a bone defect (3 mmφ x 4 mm L) artificially created in the great circle bone of a dog. After 3 weeks, the state of new bone formation was observed.
この結果、ファイバーの表面処理を行なわない場合にく
らべ表面処理を行なったファイバーは、[pH]8.0
で表面処理を行った場合を除き、いずれの場合も、より
多量の新生骨の生成が見られた。[PH18,0で表面
処理を行った場合は、表面処理を行わないで使用した場
合とほぼ同じであった・
[本発明の効果j
(1)本発明の無機ファイバーの製造方法が発明された
ことにより、従来存在しなかったりん酸カルシウムを含
み骨生成能のすぐれた新規の無機ファイバーが始めてB
1出された。As a result, the surface-treated fiber had a [pH] of 8.0 compared to the case where the fiber was not surface-treated.
In all cases, a larger amount of new bone was generated, except when the surface was treated with . [When the surface was treated at pH 18.0, it was almost the same as when it was used without surface treatment.] [Effects of the present invention j (1) The method for producing inorganic fibers of the present invention was invented. As a result, for the first time, a new inorganic fiber containing calcium phosphate and excellent bone-forming ability, which did not exist before, has been developed.
1 was issued.
(2)本発明の無機ファイバーの製造方法は、りん酸カ
ルシウム分の他にA1203 .5iO2tt相当量用
いるので、熔融、清澄、紡糸するに当たり、殆ど断糸す
ることなく長wA、Ilを製造することができる。(2) The method for producing the inorganic fiber of the present invention includes A1203. Since the amount equivalent to 5iO2tt is used, long wA and Il can be produced with almost no yarn breakage during melting, refining, and spinning.
(3)本発明の製造方法による生産物の効果としては、
長ファイバーはそのまま骨欠損部等に充填材として用い
ることもできるが、織物状とすることにより同様の方法
で若しくは該欠損部又は骨折個所算の周囲に巻きつけて
1用いることができる。(3) The effects of the product produced by the production method of the present invention are as follows:
The long fibers can be used as they are as a filling material for bone defects, etc., but by making them into a fabric, they can be used in the same manner or by being wrapped around the defect or fracture site.
骨欠損部にファイバーを充填し、更にその周囲に織物状
として巻きつけるという方法をとれば骨欠損部の修復又
は回復は、骨欠損部にファイバーを充填したのみの場合
にくらべ治療期間が短縮される。By filling the bone defect with fibers and wrapping the fibers around it in the form of a fabric, the treatment period for repairing or restoring the bone defect can be shortened compared to when the bone defect is only filled with fibers. Ru.
(4)本発明に係る無機ファイバーは単に外科及び整形
外科の分野への用途のみばかりでなく歯科における抜歯
後の1堤低下防止のため、又は歯槽膿漏等によって生じ
た歯根部周辺の骨欠損部などへの利用も当然回部であり
、更にりん酸基を含む水の処理材としても用いることが
できる。(4) The inorganic fiber according to the present invention can be used not only in the fields of surgery and orthopedics, but also in dentistry to prevent ridge drop after tooth extraction, or bone loss around the tooth root caused by alveolar pyorrhea, etc. Of course, it can also be used as a water treatment material containing phosphoric acid groups.
Claims (2)
なり、かつCaO+P_2O_5が80重量[%]未満
15重量[%]以上となる原料を、熔融工程と清澄化工
程とファイバー化工程とによりファイバーとすることを
特徴とする、無機ファイバーの製造方法。(1) A raw material with a Ca/P molar ratio of 0.3 or more and 4.0 or less after melting and a CaO+P_2O_5 of less than 80 weight [%] and 15 weight [%] or more is processed through a melting process, a clarification process, and a fiberization process. A method for producing an inorganic fiber, characterized by forming the fiber into a fiber by a process.
ファイバーを、りん酸基を含みかつ [pH]が2ないし7である溶液に浸漬することを、特
徴とする、無機ファイバーの製造方法。(2) A method for producing an inorganic fiber, characterized by immersing the fiber produced by the production method according to claim 1 in a solution containing a phosphoric acid group and having a pH of 2 to 7. .
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63243933A JPH01148812A (en) | 1988-09-30 | 1988-09-30 | Production of inorganic fiber |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63243933A JPH01148812A (en) | 1988-09-30 | 1988-09-30 | Production of inorganic fiber |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56146182A Division JPS5854023A (en) | 1981-09-18 | 1981-09-18 | Inorganic fiber |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH01148812A true JPH01148812A (en) | 1989-06-12 |
| JPH0236684B2 JPH0236684B2 (en) | 1990-08-20 |
Family
ID=17111187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63243933A Granted JPH01148812A (en) | 1988-09-30 | 1988-09-30 | Production of inorganic fiber |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH01148812A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0345266A (en) * | 1989-07-12 | 1991-02-26 | Mitsubishi Materials Corp | Filling material for bone-defective part and bone-vacant part |
| JPH03128063A (en) * | 1989-10-16 | 1991-05-31 | Natl Inst For Res In Inorg Mater | Water-curable type calcium phosphate cement composition |
| JPH03128062A (en) * | 1989-10-16 | 1991-05-31 | Natl Inst For Res In Inorg Mater | Water-curable type calcium phosphate cement composition |
| JPH03128061A (en) * | 1989-10-16 | 1991-05-31 | Natl Inst For Res In Inorg Mater | Water-curable type calcium phosphate cement composition |
| EP0618631A1 (en) * | 1993-03-22 | 1994-10-05 | Matsushita Electric Industrial Co., Ltd. | Fibrous solid electrolyte, cell using the electrolyte and process for producing the electrolyte |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04181079A (en) * | 1990-11-13 | 1992-06-29 | Hitachi Metals Ltd | Pneumatic operating valve |
-
1988
- 1988-09-30 JP JP63243933A patent/JPH01148812A/en active Granted
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0345266A (en) * | 1989-07-12 | 1991-02-26 | Mitsubishi Materials Corp | Filling material for bone-defective part and bone-vacant part |
| JPH03128063A (en) * | 1989-10-16 | 1991-05-31 | Natl Inst For Res In Inorg Mater | Water-curable type calcium phosphate cement composition |
| JPH03128062A (en) * | 1989-10-16 | 1991-05-31 | Natl Inst For Res In Inorg Mater | Water-curable type calcium phosphate cement composition |
| JPH03128061A (en) * | 1989-10-16 | 1991-05-31 | Natl Inst For Res In Inorg Mater | Water-curable type calcium phosphate cement composition |
| EP0618631A1 (en) * | 1993-03-22 | 1994-10-05 | Matsushita Electric Industrial Co., Ltd. | Fibrous solid electrolyte, cell using the electrolyte and process for producing the electrolyte |
| US5589296A (en) * | 1993-03-22 | 1996-12-31 | Matsushita Electric Industrial Co., Ltd. | Fibrous solid electrolyte, cell using the electrolyte and process for producing the electrolyte |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0236684B2 (en) | 1990-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5013323A (en) | Implant material for replacing hard tissue of living body | |
| US4735857A (en) | Fiber glass mainly composed of calcium phosphate | |
| US5238491A (en) | Hardening material for medical and dental use | |
| US6224635B1 (en) | Implantation of surgical implants with calcium sulfate | |
| Trisi et al. | Histologic effect of pure-phase beta-tricalcium phosphate on bone regeneration in human artificial jawbone defects. | |
| US4725234A (en) | Alveolar bone grafting process with controlled surface active ceramics | |
| US5429996A (en) | Bone grafting material | |
| US8715744B2 (en) | Inorganic resorbable bone substitute material | |
| US10029028B2 (en) | Biomimetic collagen-hydroxyapatite composite material | |
| EP0193588A1 (en) | Material containing carbonate apatite and use of carbonate apatite for implants. | |
| US4820573A (en) | Fiber glass mainly composed of calcium phosphate | |
| Xiang et al. | Tissue reactions to titanium implants containing bovine bone morphogenetic protein: a scanning electron microscopic investigation | |
| CN110267688B (en) | Bone regeneration material | |
| JPH01148812A (en) | Production of inorganic fiber | |
| JPH0130927B2 (en) | ||
| Nurcahyanti et al. | Comparison of xenograft and alloplast bone grafts for infrabony bone defect: Literature review | |
| Monção et al. | Raman spectroscopy analysis of wollastonite/tricalcium Phosphate glass-ceramics after implantation in critical bone defect in rats | |
| JPS6269823A (en) | Calcium phosphate based fiber | |
| Garcés-Villalá et al. | Evaluation of two highly porous microcrystalline biphasic calcium phosphate-based bone grafts for bone regeneration: an experimental study in rabbits | |
| Ferreira et al. | Biogran Grafting in Rat Tibia Defects-A Model of High Bone Metabolism Site | |
| Devesa et al. | SiO2-based glass/bone interfacial reactions | |
| KR100362699B1 (en) | Deproteinated bovine bone powder coated by calcium phosphate thin film | |
| US20240025800A1 (en) | Glass-ceramic composite material | |
| US9238047B1 (en) | Fluorapatite nano-crystalline coated non-ceramic hydrophilic hydroxylapatite bone grafting compositions and methods for promoting bone regeneration | |
| Schepers et al. | Interfacial tissue response to bioactive glasses with reduced surface reactivity |